Slide 1: Owlet, Inc. Q2 2025 Financial Results
Owlet, Inc. (NYSE: OWLT) Q2 2025 Financial Results August 7, 2025 March 4, 2025 1
Slide 2: Conference Call
Owlet, Inc. (NYSE: OWLT) | Q2 2025 Financial Results Conference Call Speakers ● Kurt Workman, CEO and Co-Founder ● Jonathan Harris, President ● Amanda Twede Crawford, CFO ● Jay Gentzkow, VP Investor Relations and Corporate Development Webcast ● Domestic Callers: (833) 470-1428 ● International Caller
Slide 3: Disclaimer
Disclaimer Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements contained in this presentation that do not relate to matters of historical fact should be consider
Slide 4: Owlet Business Update
Owlet Business Update Confidential | 4
Slide 5: Owlet Business Update | Second Quarter 2025
Owlet Business Update | Second Quarter 2025 Revenue Gross Margin Adj. EBITDA $26.1M 51.3% $0.3M Growth of 25.9% y/y Expanded 180 bps y/y Improved $0.2M y/y Business Highlights ● Financial performance exceeded expectations across all key metrics ○ Strong 26% y/y revenue growth ○ Gross margin expansio
Slide 6: Drive Continued Global Adoption of Dream Sock
Drive Continued Global Adoption of Dream Sock ● Domestic Dream Sock sell-through = 37% growth y/y ● Dream Sock registry additions = 54% growth y/y ● Dream Sock NPS = 73+ ● Record setting U.S. Amazon Prime Day sales ○ #1 seller in baby monitor and baby safety categories in U.S. ○ Total sell-through u
Slide 7: Owlet360 Pediatric Health Subscription
Owlet360 Pediatric Health Subscription Supporting parents from infancy into the toddler years & increasing LTV ● Owlet360 growth to over 66,000 paying subscribers ● Strong growth across MRR, attach rate, retention rate, and consumer satisfaction ● Launched Sleep Position, giving parents visibility i
Slide 8: Expand Medical & Healthcare Channels
Expand Medical & Healthcare Channels Insurance reimbursed health monitors for high-risk babies ● Developing Owlet Connect, our proprietary enterprise data integration platform and service ○ For first time ever, share BabySat data real-time with pediatricians ○ Integrate Owlet pediatric data into cli
Slide 9: Financial Highlights
Financial Highlights Confidential | 9
Slide 10: Financial Review | Q2 2025
Financial Review | Q2 2025 Revenue Gross Margin ● $26.1M Q2ʼ25 revenue ● 51.3% Q2ʼ25 gross margin ● 25.9% growth y/y ● 180 bps expansion y/y $ in millions Confidential | 10
Slide 11: Financial Review | Q2 2025
Financial Review | Q2 2025 Operating Expenses Adj. EBITDA ● $15.3M Q2ʼ25 total operating expenses ● $0.3M Q2ʼ25 adj. EBITDA ● OpEx as a percentage of revenue was 58.7% vs. ● $0.2M improvement vs. Q2ʼ24 60.4% in Q2ʼ24 $ in millions $ in millions Note: Adjusted EBITDA is defined as net loss adjusted f
Slide 12: Updating FY 2025 Guidance
Updating FY 2025 Guidance Previous New 2025E Guidance Guidance Revenue $91M – $95M $97M – $100M 24-28% growth y/y Including new, increased Gross Margin 46% – 50% 46% – 50% tariff costs Strive for Fully expect to Including new, increased Adj. EBITDA positive be positive tariff costs Note: Adjusted EBIT
Slide 13: Q&A
Q&A Confidential | 13